|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Property tax receivable | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Property tax receivable | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property and equipment | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Series 3 Convertible Preferred Stock | ||||||||||||||||||||
| Total contract liabilities | ||||||||||||||||||||
| Taxes payable | ||||||||||||||||||||
| Current portion of notes payable | ||||||||||||||||||||
| Advances from a related party | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Long Term Liabilities | ||||||||||||||||||||
| Notes payable, net of current portion | ||||||||||||||||||||
| Notes payable, net of current portion | ||||||||||||||||||||
| Total Long-term Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Preferred stock, value | ||||||||||||||||||||
| Series 2 Convertible Preferred Stock | ||||||||||||||||||||
| Series 3 Convertible Preferred Stock | ||||||||||||||||||||
| Series 5 Convertible Preferred Stock | ||||||||||||||||||||
| Series 3 Convertible Preferred Stock | ||||||||||||||||||||
| Common stock, par value $0.01; at June 30, 2026 and June 30, 2025, authorized 60,000,000 shares; issued and outstanding 3,292,945 and 3,292,945 shares, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| TOTAL STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
Loading...
